This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Helicobacter pylori (H. pylori) is a type of bacteria that can infect the stomach and cause gastritis, ulcers, and even stomach cancer. Fortunately, H. pylori can be treated with antibiotics. Treatment for H. pylori typically includes a combination of antibiotics, such as amoxicillin and clarithromycin, and a proton pump inhibitor (PPI). PPIs reduce the amount of acid in the stomach and help the antibiotics to work better. The antibiotics used to treat H. pylori are typically taken for one or two weeks, depending on the type of antibiotic. During this time, it is important to take the medication exactly as prescribed by your doctor. It is also important to finish all of the medication, even if you feel better after a few days. Stopping the medication too early can cause the infection to come back. Your doctor may also recommend taking a PPI in addition to the antibiotics. These medications work by reducing the amount of acid produced by the stomach. This makes it easier for the antibiotics to fight the H. pylori bacteria. The PPI is usually taken for four to eight weeks, depending on your doctor’s recommendation. After completing the H. pylori therapy, your doctor may recommend further tests to make sure the infection is gone. These tests may include a breath test, stool sample, or endoscopy. Depending on the results of these tests, your doctor may recommend additional treatments or follow-up tests. H. pylori therapy is usually very effective and the infection can be cured in most cases. However, it is important to finish all of the medication as prescribed by your doctor and to follow up with your doctor if you have any concerns.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States